Tuesday, November 11, 2025

Stocks to Watch for Oct 23: PNB, BEL, Dr Reddy’s, Tata Motors and more

Date:

PNB’s stake sale in Canara HSBC Life, BEL’s fresh order win, Dr Reddy’s USFDA update, and strong festive deliveries by Tata Motors are among the key triggers likely to move these stocks on Thursday.

3 Min Read

CNBCTV18 on Google

Image count1 / 9

Punjab National Bank: PNB has divested 10% of its stake in Canara HSBC Life Insurance Company, reducing its holding to 13%. The lender raised about ₹1,007 crore through the sale of 9.5 crore shares at ₹106 apiece. Shares of PNB will be in focus after this strategic divestment announcement.

BEL share price, BEL shares, BEL Stock, Bharat Electronics Share price, Bharat Electronics Stock, Bharat Electronics shares, BEL orders, BEL new orders, latest on BEL, BEL latest, BEL all time high

Image count2 / 9

Bharat Electronics Ltd: Navratna defence PSU will be in focus after winning a ₹633 crore order from Cochin Shipyard. The contract involves supplying equipment for sensors, weapon systems, and communication mechanisms. The order win adds to its strong order book and could boost sentiment around the stock.

Alembic Pharma share price, Alembic Pharma stock, Alembic Pharma shares, Alembic Pharma USFDA nod, Alembic Pharma gets USFDA approval, Alembic Pharma epilepsy treatment drug, Alembic Pharma anit-convulsant drug,

Image count3 / 9

Dr. Reddy’s Laboratories Ltd: Dr. Reddy’s said its Srikakulam manufacturing facility in Andhra Pradesh received Voluntary Action Indicated (VAI) status from the USFDA. The regulator issued an Establishment Inspection Report, closing the inspection with no major observations. The update removes a key compliance overhang and could lend support to the stock.

Jain Resource Recycling IPO

Image count4 / 9

Jain Resource Recycling Ltd: Newly listed company reported its first quarterly results with Net sales for the June quarter up 3.5% year-on-year to ₹1,549 crore, but EBITDA fell 4.1% to ₹90.2 crore, with margins narrowing to 5.82%. Investors will watch the stock’s reaction to its maiden post-listing financial performance.

torrent Pharmaceuticals share price

Image count5 / 9

Torrent Pharmaceuticals Ltd: Torrent Pharma shares are expected to be in focus after fair trade regulator CCI approved its proposed ₹19,500 crore acquisition of JB Chemicals and Pharmaceuticals, subject to certain voluntary modifications. The approval clears a key regulatory hurdle.

Tata Motors share price, Tata Motors stock, Tata Motors shares, Tata Motors, Tata Motors GST cut, Tata Motors deliveries, Tata Motors inquiries, Tata Motors enquiries, Tata Motors bookings, Tata Motors festive season, Tata Motors navratri day 1, Tata Motors GST rate cut impact, Tata Motors monthly sales, Tata Motors sales, GST, GST 2.0, GST 2.0 impact, Tata Motors GST 2.0,

Image count6 / 9

Tata Motors Ltd: Tata Motors Passenger Vehicles said it delivered over one lakh vehicles during the 30-day festive period between Navratri and Diwali, marking a 33% year-on-year growth. Deliveries were led by SUVs and strong EV sales. Managing Director Shailesh Chandra said the milestone underscores the company’s strong festive demand momentum.

NMDC, NMDC share price, NMDC stock, NMDC shares

Image count7 / 9

NMDC Ltd: State-run miner has revised iron ore prices with effect from October 22. Baila Lump (65.5%) will now cost ₹5,550 per tonne, while Baila Fines (64%) are priced at ₹4,750 per tonne. The stock, which gained 0.6% in Muhurat trading, has risen nearly 15% so far in 2025.

ola electric, ola, bhavish aggarwal, ola electric share price, ola electric stock, ola electric shares, ola electric collateral top up, ola electric collateral, ola,

Image count8 / 9

Ola Electric: Ola Electric remains in the spotlight as the investigation into the death of company engineer K. Aravind continues. The Karnataka High Court has granted temporary protective orders to CEO Bhavish Aggarwal and a senior company executive named in the FIR. The company has denied any wrongdoing.

Laurus Labs shares

Image count9 / 9

Laurus Labs Ltd: Brokerage firm B&K Securities initiated coverage with a ‘Buy’ rating and a price target of ₹1,030, implying an 18% upside from current levels. The brokerage said high-margin CDMO franchise is emerging as a key earnings driver, positioning it for a strong growth phase.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

UPL Q2 Results: FY26 EBITDA guidance raised, revenue projection unchanged; Stock recovers

Shares of UPL Ltd. recovered from the lows of...

When and how to dispute your credit information report to safeguard your credit score

आपकी क्रेडिट रिपोर्ट में त्रुटियां और ग़लतियां आपके क्रेडिट...

Kashmiri Doctor arrested in Faridabad with Kalashnikov rifle, 2,900 Kg explosives; Police uncover ‘white-collar’ terror module

In a major counterterrorism breakthrough, police have arrested a...

SBI Funds Management IPO: Listing likely in 2026; Parent to divest 6.3% stake

India's largest lender, State Bank of India (SBI), has...